GABAA receptor signaling in caudal periaqueductal gray regulates maternal aggression and maternal care in mice.
Maternal aggression (maternal defense) is exhibited by lactating females towards intruders and contributes to the protection of offspring. Enhancement of Gamma-Aminobutyric acid (GABA)(A) receptor signaling by benzodiazepines elevates maternal aggression, and we previously found indirect evidence (via c-Fos immunohistochemistry) that caudal periaqueductal gray (cPAG) and lateral septum (LS) could be sites where benzodiazepines increase aggression. We recently found that GABA(A) receptor signaling in LS modulates maternal aggression, and in this study, we tested the hypothesis that GABA(A) receptor signaling in cPAG also regulates this behavior. Site-directed injections to cPAG were made in lactating mice using the GABA(A) receptor antagonist, bicuculline (3-9 ng) or the GABA(A) receptor positive modulator, chlordiazepoxide (CDP), a benzodiazepine (2.5-20 microg). Maternal aggression, other maternal behaviors, and anxiety-like measures (using the light-dark box) were then examined. GABA(A) receptor positive modulator did not increase aggression, which could have resulted from a ceiling effect. However, 8 ng and 9 ng of bicuculline in cPAG significantly decreased maternal aggression without altering other maternal behaviors or light-dark box performance, suggesting some GABA(A) receptor signaling in cPAG is required for full maternal aggression expression. Additionally, 7 ng of bicuculline significantly increased licking/grooming of pups, and decreased the number of transitions between the light and dark compartments of the light-dark box without affecting aggression. Given these results indicating that antagonizing GABA(A) receptor in cPAG dose-dependently promotes offspring grooming behavior while impairing aggression, it is possible that the cPAG represents a key site for decision making (aggression versus other behaviors) in the lactating female.
Lee
Grace
G
University of Wisconsin, Zoology Department, 1117 West Johnson Street, Madison, WI 53706, USA. glee1@wisc.edu
Gammie
Stephen C
SC
D000374:Aggression / Q000187:drug effects / Q000502:physiology*; D000818:Animals; D001640:Bicuculline / Q000008:administration & dosage / Q000494:pharmacology; D002707:Chlordiazepoxide / Q000008:administration & dosage / Q000494:pharmacology; D002755:Choice Behavior / Q000187:drug effects / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D005260:Female; D058785:GABA-A Receptor Agonists; D058787:GABA-A Receptor Antagonists; D008297:Male; D008425:Maternal Behavior / Q000187:drug effects / Q000502:physiology*; D051379:Mice; D008813:Mice, Inbred ICR; D008845:Microinjections; D010487:Periaqueductal Gray / Q000187:drug effects / Q000502:physiology*; D011963:Receptors, GABA-A / Q000502:physiology*; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology*
D058785:GABA-A Receptor Agonists; D058787:GABA-A Receptor Antagonists; D011963:Receptors, GABA-A; D002707:Chlordiazepoxide; D001640:Bicuculline
J Neurosci. 1997 May 1;17(9):3364-78
9113892
Horm Behav. 1974 Dec;5(4):275-82
4477150
Brain Res. 1991 Mar 15;543(2):201-12
2059832
Neurosci Biobehav Rev. 2002 Dec;26(8):869-88
12667494
J Neurosci. 2006 Sep 6;26(36):9142-52
16957071
Behav Brain Res. 2005 Mar 7;158(1):53-68
15680194
Neuroscience. 2000;98(4):759-70
10891619
J Comp Neurol. 1985 Nov 15;241(3):285-310
4086658
Horm Behav. 2000 Aug;38(1):13-20
10924282
Physiol Behav. 1983 Jun;30(6):945-57
6611699
Stress. 2006 Sep;9(3):171-80
17060051
Neuropharmacology. 1996;35(8):1081-91
9121611
Behav Neurosci. 1998 Dec;112(6):1502-18
9926832
Neuroscience. 1998 Jan;82(1):201-21
9483515
J Comp Neurol. 1990 Dec 8;302(2):370-7
2289975
J Comp Neurol. 1984 Nov 1;229(3):374-92
6150049
Braz J Med Biol Res. 2005 Apr;38(4):597-602
15962186
J Comp Neurol. 1995 Jan 23;351(4):568-84
7721984
Neurosci Lett. 1990 Sep 18;117(3):285-8
1710039
Eur J Neurosci. 2001 Oct;14(8):1275-86
11703456
Eur J Pharmacol. 2003 Feb 28;463(1-3):55-65
12600702
Behav Genet. 2006 Sep;36(5):713-22
16676225
J Neurosci Methods. 2005 Aug 15;146(2):191-7
16054509
Behav Neurosci. 2005 Aug;119(4):1061-71
16187834
Brain Res. 1985 Mar 18;330(1):109-19
2859082
Brain Res. 1990 Jan 15;507(1):51-6
2302579
Psychopharmacology (Berl). 1985;86(1-2):68-76
3927368
Behav Neurosci. 2009 Dec;123(6):1169-77
20001101
Prog Neurobiol. 1995 Aug;46(6):575-605
8545545
J Comp Neurol. 1992 Jul 15;321(3):488-99
1506482
Behav Neurosci. 2004 Aug;118(4):805-14
15301606
Pain. 1990 Feb;40(2):195-204
2308765
Prog Neuropsychopharmacol Biol Psychiatry. 2001 Jan;25(1):91-140
11263761
J Neurosci. 1999 Sep 15;19(18):8027-35
10479702
Physiol Behav. 1981 Feb;26(2):253-8
7195046
Psychopharmacology (Berl). 2005 Sep;181(2):347-57
15830228
J Comp Neurol. 1995 Jan 23;351(4):585-601
7721985
Neuroscience. 2000;100(3):557-68
11098119
Brain Res Brain Res Rev. 2004 Aug;46(1):71-117
15297155
Pharmacol Biochem Behav. 2007 Jan;86(1):176-87
17275080
J Psychiatry Neurosci. 1994 Jan;19(1):24-9
8148363
Brain Res. 1985 May 6;333(2):325-9
3995298
Neurosci Biobehav Rev. 2001 Dec;25(7-8):669-78
11801292
Pain. 2008 Nov 30;140(2):376-386
18926635
Brain Res. 2006 Sep 7;1108(1):147-56
16828713
J Neurocytol. 1990 Oct;19(5):686-96
1706415
Brain Res. 1993 Oct 1;623(2):267-77
8221108
J Comp Neurol. 1992 Jan 1;315(1):1-15
1371779
Neurosci Biobehav Rev. 2001 Dec;25(7-8):697-709
11801295
Neuropsychopharmacology. 2007 Jul;32(7):1531-9
17164814
Int J Law Psychiatry. 2009 Jul-Aug;32(4):209-15
19596153
J Neuroendocrinol. 2006 Aug;18(8):553-66
16867176
Eur J Pharmacol. 1991 Jul 23;200(1):147-53
1685120
J Neurophysiol. 1983 Mar;49(3):567-81
6300350
Brain Res. 1981 Nov 16;224(2):279-90
7284844
Brain Res. 2001 Apr 20;898(2):232-41
11306009
J Comp Physiol Psychol. 1975 Sep;89(7):711-21
1236874
Brain Res. 1998 Aug 31;804(1):21-35
9729249
Neuroscience. 1987 Feb;20(2):365-83
3035421
J Comp Neurol. 1991 Jan 1;303(1):121-31
1706363
Pharmacol Biochem Behav. 1987 Mar;26(3):577-84
3575374
Behav Neurosci. 2009 Apr;123(2):356-68
19331459
Behav Brain Res. 1998 May;92(2):157-67
9638958
Neuroscience. 2002;114(3):675-87
12220569
Psychopharmacology (Berl). 1989;97(3):339-42
2497482
J Comp Neurol. 1981 Nov 1;202(3):335-56
7298902
Behav Brain Res. 1993 Dec 20;58(1-2):123-31
8136040
Psychopharmacology (Berl). 1989;97(2):152-3
2567023
Prog Neurobiol. 1988;31(4):261-83
3045882
Dev Psychobiol. 1976 Mar;9(2):137-48
986971
J Comp Neurol. 1990 Dec 8;302(2):378-93
2289976
Neuroscience. 1988 Oct;27(1):183-91
3200438
Pharmacol Biochem Behav. 2000 Jun;66(2):389-96
10880695
Psychopharmacology (Berl). 1997 Dec;134(4):392-400
9452182
Behav Cogn Neurosci Rev. 2005 Jun;4(2):119-35
16251728
Psychopharmacology (Berl). 1986;90(2):278-80
3097713
Eur J Pharmacol. 1990 Sep 18;189(2-3):143-8
2174788
Neuroscience. 1978;3(9):785-96
714251
Dis Nerv Syst. 1965 Mar;26:181-3
14262233
Neuroscience. 2009 Feb 18;158(4):1215-23
19118604
Pharmacol Biochem Behav. 1996 May;54(1):175-82
8728555
J Neurophysiol. 1983 Mar;49(3):582-94
6300351
J Physiol Paris. 1996;90(1):15-25
8803851
Neuropsychopharmacology. 2008 Apr;33(5):1049-61
17625503